Your browser doesn't support javascript.
loading
Effects of ABCB1 and ABCG2 Polymorphisms on the Pharmacokinetics of Abemaciclib Metabolites (M2, M20, M18).
Maeda, Akimitsu; Ando, Hitoshi; Irie, Kei; Hashimoto, Naoya; Morishige, Jun-Ichi; Fukushima, Shoji; Ebi, Hiromichi; Uchida, Kosaku; Iwata, Hiroji; Sawaki, Masataka.
Affiliation
  • Maeda A; Department of Pharmacy, Aichi Cancer Center Hospital, Nagoya, Japan; m.akimitsu@aichi-cc.jp.
  • Ando H; Department of Cellular and Molecular Function Analysis, Kanazawa University Graduate School of Medical Sciences, Kanazawa, Japan.
  • Irie K; Department of Pharmaceutics, Faculty of Pharmaceutical Science, Kobe Gakuin University, Kobe, Japan.
  • Hashimoto N; Department of Pharmacy, Kobe City Hospital Organization, Kobe City Medical Center General Hospital, Kobe, Japan.
  • Morishige JI; Department of Pharmacy, Aichi Cancer Center Hospital, Nagoya, Japan.
  • Fukushima S; Department of Cellular and Molecular Function Analysis, Kanazawa University Graduate School of Medical Sciences, Kanazawa, Japan.
  • Ebi H; Department of Pharmaceutics, Faculty of Pharmaceutical Science, Kobe Gakuin University, Kobe, Japan.
  • Uchida K; Division of Molecular Therapeutics, Aichi Cancer Center Research Institute, Nagoya, Japan.
  • Iwata H; Department of Pharmacy, Aichi Cancer Center Hospital, Nagoya, Japan.
  • Sawaki M; Department of Breast Oncology, Aichi Cancer Center Hospital, Nagoya, Japan.
Anticancer Res ; 43(3): 1283-1289, 2023 Mar.
Article in En | MEDLINE | ID: mdl-36854511

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Antineoplastic Agents Limits: Female / Humans Language: En Journal: Anticancer Res Year: 2023 Document type: Article Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Antineoplastic Agents Limits: Female / Humans Language: En Journal: Anticancer Res Year: 2023 Document type: Article Country of publication: